A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of AMG 592 in Healthy Japanese Participants

Clinical trial NCT05885451 · COMPLETED

Trial details

NCT number: NCT05885451
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Graft-versus-Host Disease (cGVHD)

Start date: 2019-01-29
Primary completion: 2019-04-11
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.